中国实验诊断学
中國實驗診斷學
중국실험진단학
CHINESE JOURNAL OF LABORATORY DIAGNOSIS
2014年
8期
1239-1242
,共4页
李文臣%崔佳乐%李日%罗毅男%洪新雨
李文臣%崔佳樂%李日%囉毅男%洪新雨
리문신%최가악%리일%라의남%홍신우
髓母细胞瘤%室管膜瘤%脑脊液%双向差异凝胶电泳
髓母細胞瘤%室管膜瘤%腦脊液%雙嚮差異凝膠電泳
수모세포류%실관막류%뇌척액%쌍향차이응효전영
Differential gel electrophoresis%medulloblastoma%ependymoma%cerebrospinal fluid
目的:建立脑脊液双向差异凝胶电泳方法,寻找髓母细胞瘤脑脊液、室管膜瘤脑脊液与正常脑脊液三者之间的差异蛋白表达。方法选取3例已确诊髓母细胞瘤患者脑脊液等体积混合为髓母细胞瘤组(M);3例已确诊室管膜瘤患者脑脊液等体积混合为室管膜瘤组(E);3例正常脑脊液等体积混合为正常对照组(CON);分别采用10%TCA/冰丙酮沉淀法除盐提取蛋白;蛋白等量混合为内标组(S);将各组蛋白分别经花青染料 Cy2、Cy3和 Cy5标记,混合后进行双向差异凝胶电泳(2D-DIGE),分别在波长488 nm、532 nm 和633 nm 激发光下扫描,所获得图像用 DeCy-der 5.0图像软件进行蛋白质表达差异分析。结果DeCyder 的胶内差异分析(DIA)模块显示胶1、胶2和胶3分别检测到1552、1547和1566个蛋白质点。DeCyder 的生物学差异分析(BVA)模块显示表达量变化超过两倍的差异蛋白质点,在髓母细胞瘤组与正常对照组中有36个;室管膜瘤组与正常对照组中有71个;而髓母细胞瘤组与室管膜瘤组中有52个。其中仅在髓母细胞瘤中上调的蛋白质点有8个,仅在室管膜组中升高的蛋白质点10个。结论脑脊液双向差异凝胶电泳方法的成功建立,为髓母细胞瘤与室管膜瘤脑脊液中标志蛋白探寻研究奠定了基础。
目的:建立腦脊液雙嚮差異凝膠電泳方法,尋找髓母細胞瘤腦脊液、室管膜瘤腦脊液與正常腦脊液三者之間的差異蛋白錶達。方法選取3例已確診髓母細胞瘤患者腦脊液等體積混閤為髓母細胞瘤組(M);3例已確診室管膜瘤患者腦脊液等體積混閤為室管膜瘤組(E);3例正常腦脊液等體積混閤為正常對照組(CON);分彆採用10%TCA/冰丙酮沉澱法除鹽提取蛋白;蛋白等量混閤為內標組(S);將各組蛋白分彆經花青染料 Cy2、Cy3和 Cy5標記,混閤後進行雙嚮差異凝膠電泳(2D-DIGE),分彆在波長488 nm、532 nm 和633 nm 激髮光下掃描,所穫得圖像用 DeCy-der 5.0圖像軟件進行蛋白質錶達差異分析。結果DeCyder 的膠內差異分析(DIA)模塊顯示膠1、膠2和膠3分彆檢測到1552、1547和1566箇蛋白質點。DeCyder 的生物學差異分析(BVA)模塊顯示錶達量變化超過兩倍的差異蛋白質點,在髓母細胞瘤組與正常對照組中有36箇;室管膜瘤組與正常對照組中有71箇;而髓母細胞瘤組與室管膜瘤組中有52箇。其中僅在髓母細胞瘤中上調的蛋白質點有8箇,僅在室管膜組中升高的蛋白質點10箇。結論腦脊液雙嚮差異凝膠電泳方法的成功建立,為髓母細胞瘤與室管膜瘤腦脊液中標誌蛋白探尋研究奠定瞭基礎。
목적:건립뇌척액쌍향차이응효전영방법,심조수모세포류뇌척액、실관막류뇌척액여정상뇌척액삼자지간적차이단백표체。방법선취3례이학진수모세포류환자뇌척액등체적혼합위수모세포류조(M);3례이학진실관막류환자뇌척액등체적혼합위실관막류조(E);3례정상뇌척액등체적혼합위정상대조조(CON);분별채용10%TCA/빙병동침정법제염제취단백;단백등량혼합위내표조(S);장각조단백분별경화청염료 Cy2、Cy3화 Cy5표기,혼합후진행쌍향차이응효전영(2D-DIGE),분별재파장488 nm、532 nm 화633 nm 격발광하소묘,소획득도상용 DeCy-der 5.0도상연건진행단백질표체차이분석。결과DeCyder 적효내차이분석(DIA)모괴현시효1、효2화효3분별검측도1552、1547화1566개단백질점。DeCyder 적생물학차이분석(BVA)모괴현시표체량변화초과량배적차이단백질점,재수모세포류조여정상대조조중유36개;실관막류조여정상대조조중유71개;이수모세포류조여실관막류조중유52개。기중부재수모세포류중상조적단백질점유8개,부재실관막조중승고적단백질점10개。결론뇌척액쌍향차이응효전영방법적성공건립,위수모세포류여실관막류뇌척액중표지단백탐심연구전정료기출。
Objective To establish the method of two-dimensional differential gel electrophoresis (2D-DIGE)and to find out the differentially expressed proteins in cerebrospinal fluid (CSF)between medulloblastoma,ependymoma and normal group.Methods 3 cases of CSF of medulloblastoma (M)confirmed by postoperative pathology,then pooled by equal amount as M group;3 cases of CSF of ependymoma (E)confirmed by postoperative pathology,then pooled by e-qual amount as E group;3 cases of normal control CSF,then pooled by equal amount as Con group.The CSF samples were precipitated with cold 10% TCA/ acetone.The internal standard comprised equal amounts of proteins extracted from three groups.Internal standardand proteins from the three groups were labeled with fluorescent dyes Cy2,Cy3 and Cy5 and then pooled.2D-DIGE of labeled samples were run.2D-DIGE gels scanned with 488 nm,532 nm and 633 nm wavelength laser were analyzed by DeCyde 5.0.Results Differential in-gel analysis (DIA)module of DeCyder indicated that there were 1552,1547 and 1566 protein spots on gel 1,gel 2 and gel 3 respectively.Biological variation analysis (BVA)module of DeCyder indicated that when average ratio >2.0 or <-2.0,there were differentially expressed pro-tein spots 36 between M and Con,71 between E and Con,52 between M and E.Moreover,there were 8 up-regulated spots only in M group and 10 up-regulated spots only in M group.Conclusion The method of 2D-DIGE has been estab-lished succesfully,which provide a foundation for searching of the protein marker in the CSF of medulloblastoma or ependymoma.